Covaxin trial begins well in 2 hospitals. 10 points

Modesto Morganelli
Luglio 19, 2020

Now the vaccine will be tested only after checking the health. Live Breaking News and Coronavirus Updates, July 18.

The report said the vaccine development is led by a medical biology institute under the North's Academy of Medical Science using angiotensin-converting enzyme 2 (ACE2). AstraZeneca has not made any comments on it yet. Only 100 participants out of the 375 volunteers would be picked for the first and second phases.

The next critical phase for The University of Queensland's COVID-19 vaccine is underway, with the research effort moving out of the lab and into human trials.

This protein tricks the body into thinking it has coronavirus and triggers an immune response to defend itself. While some kinds of T-cells like the CD4+ help the immune system recognize foreign antibodies and passively help in killing them off, other kinds of cells like the CD8+ are T-cells that directly kill virus-infected and cancerous cells - thus earning them the nickname "killer T-cells". The test was done to grasp the vaccine's safety and ability to create immunity to the virus. Scientists are trying their best to fasttrack these vaccines.

"We are looking at about seven or a little more than seven months for the vaccine, provided the data is encouraging and the vaccine is proven to be effective during the trials", he noted.

CSL stands to reap billions of dollars in profits by selling a successful UQ vaccine worldwide, although UQ has only granted CSL the manufacturing rights for the current COVID-19 pandemic.

The vaccine would be offered free to the public.

According to Rai, the Ethics Committee had raised few concerns in the protocol submitted for carrying out of the trial.

Speaking to Reuters, Pankaj Patel, the Chairman of Zydus Cadila, confirmed that they expect to complete the clinical human trials of their experimental shot, ZyCoV-D, by February or March 2021.

He also said that for some initial days, only 5 participants will be administered the dose of the vaccine candidate each day which will increase to 10-15 participants per day later on. While there are enough reasons to believe so, there are always chances that situations may turn upside down, and could be followed up by an inevitable loss of hope.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE